Status:
ACTIVE_NOT_RECRUITING
Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty
Lead Sponsor:
Mayo Clinic
Conditions:
Knee Pain Chronic
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Researchers are trying to determine if knee pain can be reduced by proactively protecting the free end of the saphenous nerve versus leaving it in the standard position during total knee arthroplasty.
Detailed Description
Subjects scheduled for total knee arthroplasty will be randomized to two arms. One arm will have the standard saphenous nerve neurectomy during their surgery. The other arm will have the same neurecto...
Eligibility Criteria
Inclusion
- Primary unilateral total knee arthroplasty candidate
Exclusion
- Body Mass Index (BMI) \>40
- Inflammatory arthritis
- Unable to follow up visits (long distance from Mayo Clinic)
- Poor compliance risk
- Health condition deemed by physician to preclude patient's ability to participate in the trial
Key Trial Info
Start Date :
January 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT04028947
Start Date
January 28 2020
End Date
December 1 2025
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224